CTKB
Cytek Biosciences
$6.14
+$0.16 (+2.68%)Oct 28, 2026
Key metrics
The numbers that frame CTKB today
- Market cap
- $798.10M
- Gross margin
- 53.2%
- EV / Sales
- 3.6
- ROIC
- -14.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $3.31
- 52wk High
- $6.32
Growth
Revenue and earnings trend for CTKB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CTKB
Is Cytek Biosciences a good buy?
Yes. Cytek Biosciences has mixed quality and excellent momentum. Taken together, the setup leans positive. Growth looks weak, a caveat that does not overturn the setup. We think Cytek Biosciences is selling at a high price, which cuts against the buy case.
What is the market capitalization of CTKB?
Cytek Biosciences's market capitalization is $798.10M.
What is the 52-week high for CTKB stock?
The 52-week high for Cytek Biosciences is $6.32. The current close of $6.14 is 2.8% below that high.
What is the 52-week low for CTKB stock?
The 52-week low for Cytek Biosciences is $3.31. The current close of $6.14 is 85.5% above that low.
Does CTKB stock pay dividends?
Cytek Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CTKB?
Cytek Biosciences's Debt / Equity ratio is 0.04.